Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
作者信息
Scheinfeld Noah S
机构信息
Department of Dermatology, Columbia University, College of Physicians and Surgeons, 150 West 55th Street, New York, NY 10019, USA.
出版信息
Skinmed. 2011 May-Jun;9(3):179-80.
PMID:21675498
Abstract
摘要
相似文献
1
2
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.与活性成分及赋形剂相比，卡泊三醇加倍他米松头皮新制剂治疗头皮银屑病的随机、双盲、对照试验。
J Am Acad Dermatol. 2008 Sep;59(3):455-63. doi: 10.1016/j.jaad.2008.04.027.
3
Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.卡泊三醇和倍他米松二丙酸酯用于斑块状银屑病的局部治疗。
Expert Rev Clin Pharmacol. 2016 Jun;9(6):789-97. doi: 10.1080/17512433.2016.1179574. Epub 2016 May 13.
4
Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment.达力士（卡泊三醇0.005%和二丙酸倍他米松0.064%）软膏
Skinmed. 2006 May-Jun;5(3):136-8. doi: 10.1111/j.1540-9740.2006.05426.x.
5
A betamethasone-calcipotriene combination for psoriasis.
Med Lett Drugs Ther. 2006 Jul 3;48(1238):55-6.
6
Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.外用0.005%卡泊三烯和0.064%二丙酸倍他米松在中重度斑块状银屑病患者逐步减量后维持依那西普的疗效：一项开放标签试验的结果
J Drugs Dermatol. 2011 Aug;10(8):878-82.
7
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.聚焦于钙泊三醇倍他米松在躯干、四肢和头皮寻常型银屑病中的应用。
Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000.
8
Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.苏格兰应用钙泊三醇和倍他米松二丙酸酯复方凝胶治疗头皮银屑病的成本效果分析。
Curr Med Res Opin. 2011 Jan;27(1):269-84. doi: 10.1185/03007995.2010.541023. Epub 2010 Dec 13.
9
Zotero 插件